Bumper Offer - Urjas oil Just @ Rs. 1
Magnova is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Infant (1 month to 2 years) |
|
Based on research, the following side effects have been observed when Magnova is used -
Moderate
Mild
Is the use of Magnova safe for pregnant women?
Magnova is safe for pregnant women.
Is the use of Magnova safe during breastfeeding?
Magnova is completely safe for breastfeeding women.
What is the effect of Magnova on the Kidneys?
Magnova rarely harms the kidneys.
What is the effect of Magnova on the Liver?
Using Magnova does not have any harmful effects on the liver.
What is the effect of Magnova on the Heart?
You can take Magnova without any fear of damage to the heart.
Magnova should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Magnova unless your doctor advises you to do so -
Is this Magnova habit forming or addictive?
Magnova is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Magnova can make you feel drowsy.
Is it safe?
Yes, Magnova is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Magnova cannot treat any kind of mental disorder.
Interaction between Food and Magnova
Taking Magnova with food does not harm your health.
Interaction between Alcohol and Magnova
Information about the interaction of Magnova and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 291-292
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 729
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Maxipime™ (Cefepime Hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 291-292
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 729
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Maxipime™ (Cefepime Hydrochloride)
